(Q79361870)

English

Incidence and causes of secondary failure in treatment with tolbutamide. Experience with 2,500 patients treated up to five years

scientific article published on 01 July 1962

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

title

Incidence and causes of secondary failure in treatment with tolbutamide. Experience with 2,500 patients treated up to five years (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

author name string

R A CAMERINI-DAVALOS

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

A MARBLE

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

language of work or name

English

0 references

publication date

1 July 1962

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

published in

The Journal of the American Medical Association

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

volume

181

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

page(s)

1-4

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Identifiers

DOI

10.1001/JAMA.1962.03050270003001

1 reference

stated in

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Europe PubMed Central

PubMed ID

13875925

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13875925%20AND%20SRC:MED&resulttype=core&format=json

(Q79361870)

Incidence and causes of secondary failure in treatment with tolbutamide. Experience with 2,500 patients treated up to five years

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)